Fri, Nov 21, 2014, 10:27 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, Inc. Message Board

  • wesleydoctor wesleydoctor Jan 23, 2013 10:59 AM Flag

    Zacks " Onyx All Set For Growth" Article: Catalyst Filled 2013 for Onyx. LINK.

    Article : Catalyst-Filled 2013 for Onyx
    ZacksBy Zacks Equity Research / Updated January 23, 2013
    Onyx Pharma, which was a one-product company until a year back, has successfully transformed into a multi-product company. With two recent product approvals (Kyprolis and Stivarga) in its bag and Nexavar continuing to perform well, Onyx Pharma looks all set for growth. We expect 2013 to be a catalyst-filled year for Onyx Pharma as the company works on expanding the labels of currently marketed products and progresses with the development of other candidates.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ONXX
124.700.0000(0.00%)Sep 30 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.